BusinessAxim® Biotech Announces Addition of World-Renowned Opthamologist to Advisory BoardBy Nasdaq OMXDec 27, 2016, 2:00 PM UTC
BusinessGenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic NeuropathyBy Nasdaq OMXFeb 29, 2016, 12:00 PM UTC
BusinesspSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9By Nasdaq OMXJan 28, 2016, 3:30 PM UTC
BusinessAGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) DeficiencyBy Nasdaq OMXJan 20, 2016, 12:01 PM UTC
BusinessCeva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface DiseasesBy Nasdaq OMXJan 19, 2016, 1:00 PM UTC
BusinessAGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia and Other Retinal DiseasesBy Nasdaq OMXJan 7, 2016, 12:01 PM UTC
